Inogen, Inc. (INGN)
USD 6.84
(-2.98%)
USD 6.84
(-2.98%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -102.44 Million USD | -22.3% |
| 2022 | -83.77 Million USD | -1222.79% |
| 2021 | -6.33 Million USD | -8.65% |
| 2020 | -5.82 Million USD | -127.82% |
| 2019 | 20.95 Million USD | -59.59% |
| 2018 | 51.84 Million USD | 146.86% |
| 2017 | 21 Million USD | 2.35% |
| 2016 | 20.51 Million USD | 77.12% |
| 2015 | 11.58 Million USD | 69.72% |
| 2014 | 6.82 Million USD | -73.16% |
| 2013 | 25.43 Million USD | 4409.75% |
| 2012 | 564 Thousand USD | 128.17% |
| 2011 | -2 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -14.57 Million USD | 45.1% |
| 2024 Q2 | -5.59 Million USD | 61.65% |
| 2023 FY | -102.44 Million USD | -22.3% |
| 2023 Q4 | -26.55 Million USD | 41.92% |
| 2023 Q3 | -45.71 Million USD | -365.29% |
| 2023 Q2 | -9.82 Million USD | 51.71% |
| 2023 Q1 | -20.34 Million USD | 64.05% |
| 2022 Q1 | -14.21 Million USD | 37.87% |
| 2022 Q3 | -9.5 Million USD | -176.18% |
| 2022 Q2 | -3.44 Million USD | 75.78% |
| 2022 FY | -83.77 Million USD | -1222.79% |
| 2022 Q4 | -56.61 Million USD | -495.52% |
| 2021 Q1 | -732 Thousand USD | 85.71% |
| 2021 Q2 | 5.1 Million USD | 796.99% |
| 2021 FY | -6.33 Million USD | -8.65% |
| 2021 Q3 | 12.17 Million USD | 138.61% |
| 2021 Q4 | -22.87 Million USD | -287.92% |
| 2020 Q4 | -5.12 Million USD | -201.41% |
| 2020 FY | -5.82 Million USD | -127.82% |
| 2020 Q3 | -1.69 Million USD | -165.85% |
| 2020 Q2 | 2.58 Million USD | 262.37% |
| 2020 Q1 | -1.58 Million USD | -15.56% |
| 2019 Q1 | 5.3 Million USD | -47.22% |
| 2019 FY | 20.95 Million USD | -59.59% |
| 2019 Q4 | -1.37 Million USD | -120.03% |
| 2019 Q3 | 6.86 Million USD | -32.45% |
| 2019 Q2 | 10.16 Million USD | 91.63% |
| 2018 Q4 | 10.04 Million USD | -38.87% |
| 2018 FY | 51.84 Million USD | 146.86% |
| 2018 Q3 | 16.43 Million USD | 12.47% |
| 2018 Q2 | 14.61 Million USD | 35.81% |
| 2018 Q1 | 10.75 Million USD | 1875.25% |
| 2017 FY | 21 Million USD | 2.35% |
| 2017 Q1 | 5.93 Million USD | 12.78% |
| 2017 Q2 | 8.33 Million USD | 40.56% |
| 2017 Q3 | 7.33 Million USD | -11.99% |
| 2017 Q4 | -606 Thousand USD | -108.26% |
| 2016 FY | 20.51 Million USD | 77.12% |
| 2016 Q1 | 2.36 Million USD | -38.7% |
| 2016 Q3 | 3.45 Million USD | -32.81% |
| 2016 Q4 | 5.26 Million USD | 52.24% |
| 2016 Q2 | 5.14 Million USD | 117.42% |
| 2015 Q2 | 3.45 Million USD | 120.04% |
| 2015 Q4 | 3.85 Million USD | 43.1% |
| 2015 Q3 | 2.69 Million USD | -22.06% |
| 2015 Q1 | 1.57 Million USD | 3.49% |
| 2015 FY | 11.58 Million USD | 69.72% |
| 2014 Q4 | 1.51 Million USD | -28.79% |
| 2014 Q2 | 2.28 Million USD | 157.43% |
| 2014 Q1 | 888 Thousand USD | -95.96% |
| 2014 Q3 | 2.13 Million USD | -6.69% |
| 2014 FY | 6.82 Million USD | -73.16% |
| 2013 Q1 | 730 Thousand USD | 575.93% |
| 2013 Q2 | 1.96 Million USD | 168.49% |
| 2013 FY | 25.43 Million USD | 4409.75% |
| 2013 Q4 | 21.97 Million USD | 2738.63% |
| 2013 Q3 | 774 Thousand USD | -60.51% |
| 2012 Q4 | 108 Thousand USD | 107.81% |
| 2012 Q3 | -1.38 Million USD | 0.0% |
| 2012 FY | 564 Thousand USD | 128.17% |
| 2011 FY | -2 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | -66.265% |
| BrainsWay Ltd. | -4.19 Million USD | -2341.005% |
| Cerus Corporation | -37.48 Million USD | -173.277% |
| Envoy Medical, Inc. | -29.9 Million USD | -242.547% |
| electroCore, Inc. | -18.83 Million USD | -443.958% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -1057.616% |
| IceCure Medical Ltd | -14.65 Million USD | -599.215% |
| OrthoPediatrics Corp. | -20.97 Million USD | -388.457% |
| Lucid Diagnostics Inc. | -52.66 Million USD | -94.526% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -645.343% |
| MaxCyte, Inc. | -37.92 Million USD | -170.15% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -763.857% |
| Nexalin Technology, Inc. | -4.64 Million USD | -2103.816% |
| Orthofix Medical Inc. | -151.39 Million USD | 32.33% |
| PAVmed Inc | -64.17 Million USD | -59.64% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | -95.264% |
| RxSight, Inc. | -48.6 Million USD | -110.766% |
| Sight Sciences, Inc. | -55.54 Million USD | -84.437% |
| SI-BONE, Inc. | -43.33 Million USD | -136.406% |
| TELA Bio, Inc. | -46.66 Million USD | -119.546% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | -106.855% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -654.244% |
| Acutus Medical, Inc. | -81.66 Million USD | -25.453% |
| Talis Biomedical Corporation | -62 Million USD | -65.222% |
| Spectral AI, Inc. | -20.85 Million USD | -391.268% |
| Nano-X Imaging Ltd. | -60.77 Million USD | -68.568% |
| CVRx, Inc. | -41.19 Million USD | -148.669% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 16102.755% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -835.155% |
| Bioventus Inc. | -156.23 Million USD | 34.424% |
| Venus Concept Inc. | -37.25 Million USD | -175.031% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | -73.531% |
| LivaNova PLC | 17.54 Million USD | 683.888% |
| 908 Devices Inc. | -36.39 Million USD | -181.461% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 45.108% |
| Nemaura Medical Inc. | -14.14 Million USD | -624.342% |
| NeuroPace, Inc. | -32.95 Million USD | -210.866% |
| LENSAR, Inc. | -14.38 Million USD | -612.292% |
| Apyx Medical Corporation | -18.71 Million USD | -447.475% |
| Cutera, Inc. | -162.83 Million USD | 37.083% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -845.974% |
| BioSig Technologies, Inc. | -29.04 Million USD | -252.774% |
| Anika Therapeutics, Inc. | -82.66 Million USD | -23.93% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -363.801% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 251.236% |
| Axonics, Inc. | -6.08 Million USD | -1582.802% |
| Outset Medical, Inc. | -172.79 Million USD | 40.711% |
| IRIDEX Corporation | -9.57 Million USD | -970.522% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 3.256% |
| IRadimed Corporation | 17.19 Million USD | 695.884% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -1142.71% |
| INVO Bioscience, Inc. | -8.03 Million USD | -1175.096% |
| Telesis Bio, Inc. | -47.72 Million USD | -114.67% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 1100.185% |
| Varex Imaging Corporation | -47.7 Million USD | -114.778% |
| Quipt Home Medical Corp. | -2.78 Million USD | -3579.921% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -807.753% |
| Pulmonx Corporation | -60.84 Million USD | -68.383% |
| Dynatronics Corporation | -2.69 Million USD | -3697.616% |
| Modular Medical, Inc. | -17.47 Million USD | -486.428% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -799.701% |
| Semler Scientific, Inc. | 20.58 Million USD | 597.736% |
| InMode Ltd. | 197.91 Million USD | 151.763% |
| Bruker Corporation | 427.2 Million USD | 123.982% |
| Cytosorbents Corporation | -28.5 Million USD | -259.377% |
| DexCom, Inc. | 541.5 Million USD | 118.919% |
| Align Technology, Inc. | 445.05 Million USD | 123.02% |
| Viveve Medical, Inc. | -22.02 Million USD | -365.106% |
| ZimVie Inc. | -393.28 Million USD | 73.95% |
| Movano Inc. | -29.28 Million USD | -249.858% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -743.34% |
| Nexalin Technology, Inc. | -4.64 Million USD | -2103.816% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 16102.755% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 53.978% |
| Profound Medical Corp. | -28.56 Million USD | -258.602% |
| Insulet Corporation | 206.3 Million USD | 149.66% |
| enVVeno Medical Corporation | -23.51 Million USD | -335.657% |
| Surmodics, Inc. | -11.54 Million USD | -787.619% |
| iCAD, Inc. | -4.84 Million USD | -2013.658% |
| Nuwellis, Inc. | -20.2 Million USD | -406.947% |
| Biotricity, Inc. | -14.09 Million USD | -626.883% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 16.982% |
| Aethlon Medical, Inc. | -12.2 Million USD | -739.184% |
| InspireMD, Inc. | -19.91 Million USD | -414.406% |
| PAVmed Inc. | -64.17 Million USD | -59.64% |
| BIOLASE, Inc. | -20.63 Million USD | -396.554% |
| Beyond Air, Inc. | -60.24 Million USD | -70.062% |
| FONAR Corporation | 10.56 Million USD | 1069.482% |
| AxoGen, Inc. | -21.71 Million USD | -371.767% |
| Vivani Medical, Inc. | -25.65 Million USD | -299.38% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 459.281% |
| Inari Medical, Inc. | -1.63 Million USD | -6162.164% |
| UFP Technologies, Inc. | 44.92 Million USD | 328.05% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -1896.149% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -1451.034% |
| Tenon Medical, Inc. | -15.58 Million USD | -557.525% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -564.132% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -189.954% |
| AdaptHealth Corp. | -678.89 Million USD | 84.909% |
| Sintx Technologies, Inc. | -8.25 Million USD | -1140.453% |
| NanoVibronix, Inc. | -3.71 Million USD | -2660.684% |
| Quanterix Corporation | -32.33 Million USD | -216.846% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -807.753% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 21223.505% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 66.6% |
| TransMedics Group, Inc. | -25.02 Million USD | -309.338% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -362.879% |
| NeuroMetrix, Inc. | -6.52 Million USD | -1469.021% |
| Hyperfine, Inc. | -44.23 Million USD | -131.586% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | -30.505% |
| Biomerica, Inc. | -5.97 Million USD | -1613.767% |
| Bone Biologics Corporation | -8.94 Million USD | -1044.844% |
| AVITA Medical, Inc. | -39.16 Million USD | -161.562% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -929.236% |
| Silk Road Medical, Inc | -55.74 Million USD | -83.788% |